Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

DNA methylation analysis of cervical scrapes using FAM19A4 and mir124‐2 genes has shown a good clinical performance in detecting cervical cancer and advanced CIN lesions in need of treatment in HPV‐positive women. To date, longitudinal data on the cancer risk of methylation test‐negative women are l...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Cancer
Hlavní autoři: De Strooper, Lise M.A., Berkhof, Johannes, Steenbergen, Renske D.M., Lissenberg‐Witte, Birgit I., Snijders, Peter J.F., Meijer, Chris J.L.M., Heideman, Daniëlle A.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Cancer Therapy and Prevention
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6099282/
https://ncbi.nlm.nih.gov/pubmed/29663363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31539
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky